English | Español
Press release submission | Dec 29, 2021

NRx Pharmaceuticals Files Breakthrough Therapy Designation Request for ZYESAMI® (aviptadil) in Patients at Immediate Risk of Death from COVID-19 Despite Treatment with Remdesivir and Other Approved Therapies

Press release submission | Dec 29, 2021

Janssen Submits Biologics License Application to U.S. FDA Seeking Approval of Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Bree Gonzales | Dec 28, 2021

'With omicron on the rise,' California health care workers mandated to get COVID-19 booster shots
Bree Gonzales | Dec 27, 2021

Hochul signs legislation to 'expand access to health care and enhance services for all New Yorkers'
Press release submission | Dec 24, 2021

Berkshire VNA Nurses and Healthcare Professionals Vote Overwhelmingly to Join Massachusetts Nurses Association and Unite to Improve Conditions for Patients, Clinicians, and the Community

Press release submission | Dec 23, 2021

Florida Medical Clinic Announces Post-Acute Care Network for Patients After Hospital Discharge

Press release submission | Dec 22, 2021

FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients

Press release submission | Dec 20, 2021

FDA Approves Otezla® (Apremilast) for the Treatment of Adult Patients With Plaque Psoriasis, Regardless of Severity Level

Trending
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

Cipla leads record team at LUNG FORCE Walk NYC supporting lung health